Europe Theranostics Market Size, Share & Trends Analysis Report By End User, By Product (Radiopharmaceuticals, Diagnostic Imaging, IVD/Biomarker Screening, and Software & Services), By Application, By Country and Growth Forecast, 2023 - 2030

The Europe Theranostics Market would witness market growth of 14.8% CAGR during the forecast period (2023-2030).

The Germany market dominated the Europe Theranostics Market by Country in 2022 and would continue to be a dominant market till 2030; thereby, achieving a market value of $338.8 million by 2030. The UK market is exhibiting a CAGR of 13.7% during (2023 - 2030). Additionally, The France market would experience a CAGR of 15.7% during (2023 - 2030).

Theranostic agents, such as radiopharmaceuticals and targeted therapies, deliver therapeutic payloads directly to cancer cells while sparing healthy tissues, enhancing treatment efficacy, and minimizing side effects. Imaging techniques such as echocardiography, cardiac MRI, and computed tomography angiography (CTA) enable visualization of cardiac anatomy, function, and blood flow, aiding in diagnosing coronary artery disease, myocardial infarction, and heart failure.

Biomarker-based assays, including troponin and B-type natriuretic peptide (BNP), provide prognostic information and risk stratification for cardiovascular events. Theranostic strategies help identify high-risk patients for adverse cardiovascular outcomes, enabling personalized treatment plans and interventions to improve patient outcomes. Additionally, these also have applications in neurology for the diagnosis and management of neurological disorders such as Alzheimer’s disease, Parkinson’s disease, and stroke.

As per the Eurostat, the high incidence of cardiovascular diseases (CVDs) in Europe drives the demand for advanced diagnostic tools and techniques for early detection, risk assessment, and disease monitoring. The standardized death rate for cerebrovascular diseases in 2020 in Bulgaria (which had the highest rate among the EU Member States) was 8.4 times higher than in France. Therefore, the growing prevalence of cardiovascular disease in the region propels the market’s growth.

Free Valuable Insights: The Global Theranostics Market will Hit USD 5.4 Billion by 2030, at a CAGR of 15.2%

Based on End User, the market is segmented into Hospitals & Cancer Care Centers, Theranostics Centers, and Research & Academic Centers. Based on Product, the market is segmented into Radiopharmaceuticals, Diagnostic Imaging, IVD/Biomarker Screening, and Software & Services. Based on Application, the market is segmented into Prostate Cancer, Bone Metastasis, Other Cancers, and Others. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.

List of Key Companies Profiled

• Bayer AG
• GE HealthCare Technologies, Inc.
• Siemens Healthineers AG (Siemens AG)
• Cardinal Health, Inc.
• Canon, Inc.
• Clarity Pharmaceuticals Ltd
• Koninklijke Philips N.V.
• Thermo Fisher Scientific, Inc.
• Telix Pharmaceuticals Limited
• ABX advanced biochemical compounds GmbH

Europe Theranostics Market Report Segmentation

By End User

• Hospitals & Cancer Care Centers
• Theranostics Centers
• Research & Academic Centers

By Product

• Radiopharmaceuticals
• Diagnostic Imaging
• IVD/Biomarker Screening
• Software & Services

By Application

• Prostate Cancer
• Bone Metastasis
• Other Cancers
• Others

By Country

• Germany
• UK
• France
• Russia
• Spain
• Italy
• Rest of Europe

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Theranostics Market, by End User
1.4.2 Europe Theranostics Market, by Product
1.4.3 Europe Theranostics Market, by Application
1.4.4 Europe Theranostics Market, by Country
1.5 Methodology for the research

Chapter 2. Market at a Glance
2.1 Key Highlights

Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
3.2.3 Market Opportunities
3.2.4 Market Challenges
3.3 Porter’s Five Forces Analysis

Chapter 4. Europe Theranostics Market by End User
4.1 Europe Hospitals & Cancer Care Centers Market by Country
4.2 Europe Theranostics Centers Market by Country
4.3 Europe Research & Academic Centers Market by Country

Chapter 5. Europe Theranostics Market by Product
5.1 Europe Radiopharmaceuticals Market by Country
5.2 Europe Diagnostic Imaging Market by Country
5.3 Europe IVD/Biomarker Screening Market by Country
5.4 Europe Software & Services Market by Country

Chapter 6. Europe Theranostics Market by Application
6.1 Europe Prostate Cancer Market by Country
6.2 Europe Bone Metastasis Market by Country
6.3 Europe Other Cancers Market by Country
6.4 Europe Others Market by Country

Chapter 7. Europe Theranostics Market by Country
7.1 Germany Theranostics Market
7.1.1 Germany Theranostics Market by End User
7.1.2 Germany Theranostics Market by Product
7.1.3 Germany Theranostics Market by Application
7.2 UK Theranostics Market
7.2.1 UK Theranostics Market by End User
7.2.2 UK Theranostics Market by Product
7.2.3 UK Theranostics Market by Application
7.3 France Theranostics Market
7.3.1 France Theranostics Market by End User
7.3.2 France Theranostics Market by Product
7.3.3 France Theranostics Market by Application
7.4 Russia Theranostics Market
7.4.1 Russia Theranostics Market by End User
7.4.2 Russia Theranostics Market by Product
7.4.3 Russia Theranostics Market by Application
7.5 Spain Theranostics Market
7.5.1 Spain Theranostics Market by End User
7.5.2 Spain Theranostics Market by Product
7.5.3 Spain Theranostics Market by Application
7.6 Italy Theranostics Market
7.6.1 Italy Theranostics Market by End User
7.6.2 Italy Theranostics Market by Product
7.6.3 Italy Theranostics Market by Application
7.7 Rest of Europe Theranostics Market
7.7.1 Rest of Europe Theranostics Market by End User
7.7.2 Rest of Europe Theranostics Market by Product
7.7.3 Rest of Europe Theranostics Market by Application

Chapter 8. Company Profiles
8.1 Bayer AG
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Segmental and Regional Analysis
8.1.4 Research & Development Expense
8.1.5 Recent strategies and developments:
8.1.5.1 Acquisition and Mergers:
8.1.6 SWOT Analysis
8.2 GE HealthCare Technologies, Inc.
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Segmental and Regional Analysis
8.2.4 Research & Development Expenses
8.2.5 Recent strategies and developments:
8.2.5.1 Partnerships, Collaborations, and Agreements:
8.2.6 SWOT Analysis
8.3 Siemens Healthineers AG (Siemens AG)
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Segmental and Regional Analysis
8.3.4 Research & Development Expense
8.3.5 Recent strategies and developments:
8.3.5.1 Product Launches and Product Expansions:
8.3.6 SWOT Analysis
8.4 Cardinal Health, Inc.
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Segmental and Regional Analysis
8.4.4 SWOT Analysis
8.5 Canon, Inc.
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Segmental and Regional Analysis
8.5.4 Research & Development Expenses
8.5.5 SWOT Analysis
8.6 Clarity Pharmaceuticals Ltd
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Research & Development Expenses
8.6.4 SWOT Analysis
8.7 Koninklijke Philips N.V.
8.7.1 Company Overview
8.7.2 Financial Analysis
8.7.3 Segmental and Regional Analysis
8.7.4 Research & Development Expense
8.7.5 SWOT Analysis
8.8 Thermo Fisher Scientific, Inc.
8.8.1 Company Overview
8.8.2 Financial Analysis
8.8.3 Segmental and Regional Analysis
8.8.4 Research & Development Expenses
8.8.5 SWOT Analysis
8.9 Telix Pharmaceuticals Limited
8.9.1 Company Overview
8.9.2 Financial Analysis
8.9.3 Segmental and Regional Analysis
8.9.4 Research & Development Expenses
8.9.5 SWOT Analysis
8.10. ABX advanced biochemical compounds GmbH
8.10.1 Company Overview
8.10.2 SWOT Analysis

TABLE 1 Europe Theranostics Market, 2019 - 2022, USD Million
TABLE 2 Europe Theranostics Market, 2023 - 2030, USD Million
TABLE 3 Europe Theranostics Market by End User, 2019 - 2022, USD Million
TABLE 4 Europe Theranostics Market by End User, 2023 - 2030, USD Million
TABLE 5 Europe Hospitals & Cancer Care Centers Market by Country, 2019 - 2022, USD Million
TABLE 6 Europe Hospitals & Cancer Care Centers Market by Country, 2023 - 2030, USD Million
TABLE 7 Europe Theranostics Centers Market by Country, 2019 - 2022, USD Million
TABLE 8 Europe Theranostics Centers Market by Country, 2023 - 2030, USD Million
TABLE 9 Europe Research & Academic Centers Market by Country, 2019 - 2022, USD Million
TABLE 10 Europe Research & Academic Centers Market by Country, 2023 - 2030, USD Million
TABLE 11 Europe Theranostics Market by Product, 2019 - 2022, USD Million
TABLE 12 Europe Theranostics Market by Product, 2023 - 2030, USD Million
TABLE 13 Europe Radiopharmaceuticals Market by Country, 2019 - 2022, USD Million
TABLE 14 Europe Radiopharmaceuticals Market by Country, 2023 - 2030, USD Million
TABLE 15 Europe Diagnostic Imaging Market by Country, 2019 - 2022, USD Million
TABLE 16 Europe Diagnostic Imaging Market by Country, 2023 - 2030, USD Million
TABLE 17 Europe IVD/Biomarker Screening Market by Country, 2019 - 2022, USD Million
TABLE 18 Europe IVD/Biomarker Screening Market by Country, 2023 - 2030, USD Million
TABLE 19 Europe Software & Services Market by Country, 2019 - 2022, USD Million
TABLE 20 Europe Software & Services Market by Country, 2023 - 2030, USD Million
TABLE 21 Europe Theranostics Market by Application, 2019 - 2022, USD Million
TABLE 22 Europe Theranostics Market by Application, 2023 - 2030, USD Million
TABLE 23 Europe Prostate Cancer Market by Country, 2019 - 2022, USD Million
TABLE 24 Europe Prostate Cancer Market by Country, 2023 - 2030, USD Million
TABLE 25 Europe Bone Metastasis Market by Country, 2019 - 2022, USD Million
TABLE 26 Europe Bone Metastasis Market by Country, 2023 - 2030, USD Million
TABLE 27 Europe Other Cancers Market by Country, 2019 - 2022, USD Million
TABLE 28 Europe Other Cancers Market by Country, 2023 - 2030, USD Million
TABLE 29 Europe Others Market by Country, 2019 - 2022, USD Million
TABLE 30 Europe Others Market by Country, 2023 - 2030, USD Million
TABLE 31 Europe Theranostics Market by Country, 2019 - 2022, USD Million
TABLE 32 Europe Theranostics Market by Country, 2023 - 2030, USD Million
TABLE 33 Germany Theranostics Market, 2019 - 2022, USD Million
TABLE 34 Germany Theranostics Market, 2023 - 2030, USD Million
TABLE 35 Germany Theranostics Market by End User, 2019 - 2022, USD Million
TABLE 36 Germany Theranostics Market by End User, 2023 - 2030, USD Million
TABLE 37 Germany Theranostics Market by Product, 2019 - 2022, USD Million
TABLE 38 Germany Theranostics Market by Product, 2023 - 2030, USD Million
TABLE 39 Germany Theranostics Market by Application, 2019 - 2022, USD Million
TABLE 40 Germany Theranostics Market by Application, 2023 - 2030, USD Million
TABLE 41 UK Theranostics Market, 2019 - 2022, USD Million
TABLE 42 UK Theranostics Market, 2023 - 2030, USD Million
TABLE 43 UK Theranostics Market by End User, 2019 - 2022, USD Million
TABLE 44 UK Theranostics Market by End User, 2023 - 2030, USD Million
TABLE 45 UK Theranostics Market by Product, 2019 - 2022, USD Million
TABLE 46 UK Theranostics Market by Product, 2023 - 2030, USD Million
TABLE 47 UK Theranostics Market by Application, 2019 - 2022, USD Million
TABLE 48 UK Theranostics Market by Application, 2023 - 2030, USD Million
TABLE 49 France Theranostics Market, 2019 - 2022, USD Million
TABLE 50 France Theranostics Market, 2023 - 2030, USD Million
TABLE 51 France Theranostics Market by End User, 2019 - 2022, USD Million
TABLE 52 France Theranostics Market by End User, 2023 - 2030, USD Million
TABLE 53 France Theranostics Market by Product, 2019 - 2022, USD Million
TABLE 54 France Theranostics Market by Product, 2023 - 2030, USD Million
TABLE 55 France Theranostics Market by Application, 2019 - 2022, USD Million
TABLE 56 France Theranostics Market by Application, 2023 - 2030, USD Million
TABLE 57 Russia Theranostics Market, 2019 - 2022, USD Million
TABLE 58 Russia Theranostics Market, 2023 - 2030, USD Million
TABLE 59 Russia Theranostics Market by End User, 2019 - 2022, USD Million
TABLE 60 Russia Theranostics Market by End User, 2023 - 2030, USD Million
TABLE 61 Russia Theranostics Market by Product, 2019 - 2022, USD Million
TABLE 62 Russia Theranostics Market by Product, 2023 - 2030, USD Million
TABLE 63 Russia Theranostics Market by Application, 2019 - 2022, USD Million
TABLE 64 Russia Theranostics Market by Application, 2023 - 2030, USD Million
TABLE 65 Spain Theranostics Market, 2019 - 2022, USD Million
TABLE 66 Spain Theranostics Market, 2023 - 2030, USD Million
TABLE 67 Spain Theranostics Market by End User, 2019 - 2022, USD Million
TABLE 68 Spain Theranostics Market by End User, 2023 - 2030, USD Million
TABLE 69 Spain Theranostics Market by Product, 2019 - 2022, USD Million
TABLE 70 Spain Theranostics Market by Product, 2023 - 2030, USD Million
TABLE 71 Spain Theranostics Market by Application, 2019 - 2022, USD Million
TABLE 72 Spain Theranostics Market by Application, 2023 - 2030, USD Million
TABLE 73 Italy Theranostics Market, 2019 - 2022, USD Million
TABLE 74 Italy Theranostics Market, 2023 - 2030, USD Million
TABLE 75 Italy Theranostics Market by End User, 2019 - 2022, USD Million
TABLE 76 Italy Theranostics Market by End User, 2023 - 2030, USD Million
TABLE 77 Italy Theranostics Market by Product, 2019 - 2022, USD Million
TABLE 78 Italy Theranostics Market by Product, 2023 - 2030, USD Million
TABLE 79 Italy Theranostics Market by Application, 2019 - 2022, USD Million
TABLE 80 Italy Theranostics Market by Application, 2023 - 2030, USD Million
TABLE 81 Rest of Europe Theranostics Market, 2019 - 2022, USD Million
TABLE 82 Rest of Europe Theranostics Market, 2023 - 2030, USD Million
TABLE 83 Rest of Europe Theranostics Market by End User, 2019 - 2022, USD Million
TABLE 84 Rest of Europe Theranostics Market by End User, 2023 - 2030, USD Million
TABLE 85 Rest of Europe Theranostics Market by Product, 2019 - 2022, USD Million
TABLE 86 Rest of Europe Theranostics Market by Product, 2023 - 2030, USD Million
TABLE 87 Rest of Europe Theranostics Market by Application, 2019 - 2022, USD Million
TABLE 88 Rest of Europe Theranostics Market by Application, 2023 - 2030, USD Million
TABLE 89 Key Information – Bayer AG
TABLE 90 Key Information – GE HealthCare Technologies, Inc.
TABLE 91 Key Information – Siemens Healthineers AG
TABLE 92 key information – Cardinal Health, Inc.
TABLE 93 Key Information – Canon, Inc.
TABLE 94 Key Information – Clarity Pharmaceuticals Ltd
TABLE 95 Key Information – Koninklijke Philips N.V.
TABLE 96 Key Information – Thermo Fisher Scientific, Inc.
TABLE 97 Key Information – Telix Pharmaceuticals Limited
TABLE 98 Key Information – ABX advanced biochemical compounds GmbH

List of Figures
FIG 1 Methodology for the research
FIG 2 Europe Theranostics Market, 2019 - 2030, USD Million
FIG 3 Key Factors Impacting Theranostics Market
FIG 4 Porter’s Five Forces Analysis - Theranostics Market
FIG 5 Europe Theranostics Market share by End User, 2022
FIG 6 Europe Theranostics Market share by End User, 2030
FIG 7 Europe Theranostics Market by End User, 2019 - 2030, USD Million
FIG 8 Europe Theranostics Market share by Product, 2022
FIG 9 Europe Theranostics Market share by Product, 2030
FIG 10 Europe Theranostics Market by Product, 2019 - 2030, USD Million
FIG 11 Europe Theranostics Market share by Application, 2022
FIG 12 Europe Theranostics Market share by Application, 2030
FIG 13 Europe Theranostics Market by Application, 2019 - 2030, USD Million
FIG 14 Europe Theranostics Market share by Country, 2022
FIG 15 Europe Theranostics Market share by Country, 2030
FIG 16 Europe Theranostics Market by Country, 2019 - 2030, USD Million
FIG 17 Swot Analysis: Bayer AG
FIG 18 SWOT Analysis: GE HealthCare Technologies, Inc.
FIG 19 SWOT Analysis: Siemens Healthineers AG
FIG 20 Swot Analysis: Cardinal Health, Inc.
FIG 21 SWOT Analysis: CANON, INC.
FIG 22 SWOT Analysis: Clarity Pharmaceuticals Ltd
FIG 23 SWOT Analysis: Koninklijke Philips N.V.
FIG 24 SWOT Analysis: Thermo Fisher Scientific, Inc.
FIG 25 SWOT Analysis: TELIX PHARMACEUTICALS LIMITED
FIG 26 SWOT Analysis: ABX advanced biochemical compounds GmbH